Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
HeraMED Ltd. ( (AU:HMD) ) just unveiled an update.
HeraMED Limited has announced that its Annual General Meeting will take place on May 29, 2025, and has set April 14, 2025, as the deadline for director nominations. This announcement underscores the company’s ongoing governance activities and provides stakeholders with an opportunity to influence its strategic direction through board elections.
More about HeraMED Ltd.
HeraMED Limited is a medical data and technology company that is pioneering the digital transformation of maternity care. The company offers a hybrid maternity care platform that integrates hardware and software solutions, including the HeraBEAT in-home fetal and maternal heart rate monitor, cloud computing, artificial intelligence, and big data. Its proprietary platform, HeraCARE, is designed to provide a comprehensive maternal health ecosystem, enhancing care quality and cost-effectiveness while ensuring expectant mothers are well-supported and informed.
Technical Sentiment Signal: Strong Buy
Current Market Cap: €7.72M
See more data about HMD stock on TipRanks’ Stock Analysis page.